Historical review: Cytokines as therapeutics and targets of therapeutics.
about
Vitreous mediators in retinal hypoxic diseasesComprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.The stimulating adventure of KRN 7000.IL-32, a proinflammatory cytokine in rheumatoid arthritis.Prolonged neuroinflammation after lipopolysaccharide exposure in aged rats.Evaluation of the Effects of Some Brazilian Medicinal Plants on the Production of TNF- α and CCL2 by THP-1 Cells.Immunological consequences of thalidomide treatment in Sjögren's syndromeIdentification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachmentInterferon treatment for hypereosinophilic syndromes and systemic mastocytosis.Recent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsIn-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.Appreciating the heterogeneity in autoimmune disease: multiparameter assessment of intracellular signaling mechanisms.Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammationToll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation.Invited commentary on David Fedson's articleMany cytokines are very useful therapeutic targets in disease.Tumor necrosis factor-alpha in severe corticosteroid-refractory asthma.Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis.Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Treatment of endotoxaemia and septicaemia in the equine patient.Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway.Ticks produce highly selective chemokine binding proteins with antiinflammatory activity.Cytokine Profiles in Aqueous Humor and Plasma of HIV-infected Individuals with Ocular Syphilis or Cytomegalovirus Retinitis.Use of electrospinning and dynamic air focusing to create three-dimensional cell culture scaffolds in microfluidic devices.Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.Immuno-oncology combinations: raising the tail of the survival curve.Intrapituitary cytokines in Cushing's disease: do they play a role?Cytokine-Ion Channel Interactions in Pulmonary Inflammation.The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.IL-20 bone diseases involvement and therapeutic target potential.Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune System.
P2860
Q27028225-01C5C678-D077-48AC-90B5-58BD87F3B9D8Q33517638-CA3CDE6E-6B3F-48DD-855A-0FEB6CB1F034Q33843406-AC22DD32-9D3F-4B74-B0AE-F0A83D129331Q34480273-008CB8FA-344F-41EF-9F5F-C25114EB13F3Q35235003-2A979F44-350D-48B0-A6C8-65D0E5C4E78DQ35279021-5A1C1643-A249-4C20-9E46-D23B306C1D04Q35636539-2C5785A0-6B5D-499D-A234-550AC7612AA7Q35645859-1F6A67D4-EAF2-4F2A-914C-5A2C29F28DACQ36182744-B170BEC5-1F24-4F7B-99B1-141935630BE3Q36273796-6D408675-4353-4461-93E0-921CE21AC4ADQ36346817-A3AE73A0-56D6-4ADC-924F-078D383E0A7AQ36388675-690C63BB-EFAB-44DA-89FC-B4B05A04E25AQ36853429-E447B832-0C53-4867-A890-FDDD866B6D10Q37029607-5B69377C-F54F-4598-B6AC-C54FF973F086Q37086826-F930D232-6F59-4F52-BB39-96C7474D8413Q37316591-C5EFCEC6-81C4-4D05-9D99-DA8199E7690CQ37754950-71E10DB0-A49B-4877-8D45-B240FB8B9AEAQ38760540-BC4B47C5-3B09-4B4A-9187-B01B1188A79DQ38790815-C3A7AC37-DA6E-4695-8CA2-7C4A9E113466Q38906880-2802CA0F-C904-4C4B-9F88-1B7698C55808Q39340698-F40F628A-4077-4351-85C5-B6D0F2AF5CAFQ40063162-FE8BAAEB-2113-4AAB-814C-9000176EE1CEQ40374491-B2EC5594-696F-4397-9ABE-D91ADDECAC5CQ40989263-249C7846-F8F5-457F-9157-2D5ABADDE92BQ41412965-1D12E36A-402E-444B-8F21-A9E3F3E4C713Q42421273-C83EB942-F84A-4BBA-AD81-F4C82E1159D3Q42481647-068B99DD-B1DE-407D-9DE7-5FEADBCE29B0Q47651769-8C02E7EE-8856-438F-8990-CADEF3C274F7Q50723376-311881BB-BB32-49E2-8953-7A790CDB2D93Q55121772-41D9AB81-9D4B-45F4-87EB-822D5EF43124Q55146328-FF4725F9-D4B1-444A-A502-E5095305B0DC
P2860
Historical review: Cytokines as therapeutics and targets of therapeutics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Historical review: Cytokines as therapeutics and targets of therapeutics.
@ast
Historical review: Cytokines as therapeutics and targets of therapeutics.
@en
type
label
Historical review: Cytokines as therapeutics and targets of therapeutics.
@ast
Historical review: Cytokines as therapeutics and targets of therapeutics.
@en
prefLabel
Historical review: Cytokines as therapeutics and targets of therapeutics.
@ast
Historical review: Cytokines as therapeutics and targets of therapeutics.
@en
P1476
Historical review: Cytokines as therapeutics and targets of therapeutics.
@en
P2093
Jan Vilcek
Marc Feldmann
P304
P356
10.1016/J.TIPS.2004.02.011
P577
2004-04-01T00:00:00Z